Lineage Cell Therapeutics
LCTX
#8126
Rank
NZ$0.58 B
Marketcap
NZ$2.36
Share price
3.85%
Change (1 day)
41.93%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -NZ$35.18 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$10.81 Million. In 2024 the company made an earning of -NZ$37.61 Million, an increase over its 2023 earnings that were of -NZ$43.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$35.18 Million-6.46%
2024 -NZ$37.61 Million-13.16%
2023 -NZ$43.31 Million9.83%
2022 -NZ$39.43 Million-54.24%
2021 -NZ$86.16 Million86.07%
2020 -NZ$46.31 Million-31.97%
2019 -NZ$68.07 Million-5.42%
2018 -NZ$71.96 Million1.1%
2017 -NZ$71.18 Million-31.06%
2016 -NZ$0.11 Billion-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$88.83 Million31.68%
2013 -NZ$67.46 Million
2011 -NZ$32.74 Million89.78%
2010 -NZ$17.26 Million206.06%
2009 -NZ$5.64 Million-0.58%
2008 -NZ$5.67 Million164.89%
2007 -NZ$2.15 Million-30.22%
2006 -NZ$3.07 Million
2002 -NZ$3.57 Million-41.04%
2001 -NZ$6.05 Million-32.04%
2000 -NZ$8.89 Million-11.85%
1999 -NZ$10.09 Million
1997 -NZ$6.48 Million12.12%
1996 -NZ$5.78 Million106.25%
1995 -NZ$2.81 Million-11.11%
1994 -NZ$3.16 Million50%
1993 -NZ$2.11 Million20%
1992 -NZ$1.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 603.03%๐Ÿ‡บ๐Ÿ‡ธ USA